Recommendations for Influenza Vaccination in Immunocompromised Patients

Area of Science:

• Immunology
• Vaccinology
• Infectious Diseases

Background:

• Immunocompromised individuals face higher risks of severe influenza infections.
• Annual influenza vaccination is a key preventive measure for this vulnerable group.
• Existing vaccine efficacy may be suboptimal in certain immunocompromised populations.

Purpose of the Study:

• To update influenza vaccination recommendations for solid organ transplant recipients.
• To evaluate the use of highly immunogenic influenza vaccines in immunocompromised individuals.
• To enhance vaccine efficacy and safety in at-risk populations.

Main Methods:

• Review and revision of existing influenza vaccination guidelines by the Korean Society of Infectious Diseases.
• Consideration of data on high-dose inactivated influenza vaccines and MF59-adjuvanted inactivated influenza vaccines.
• Assessment of immunogenicity and safety profiles of advanced influenza vaccine formulations.

Main Results:

• Revised recommendations advocate for highly immunogenic vaccines (high-dose or MF59-adjuvanted) for solid organ transplant recipients.
• These advanced vaccines demonstrated improved immunogenicity compared to standard vaccines.
• No compromise in safety was observed with the use of these enhanced vaccines.

Conclusions:

• Highly immunogenic influenza vaccines show promise for improving protection in solid organ transplant recipients.
• Further research is warranted to extend these vaccination strategies to broader immunocompromised populations.
• Consideration should be given to expanding vaccination guidelines as more evidence becomes available.